Search

Summary: Background: Rhodococcus equi is an important cause of foal pneumonia. While its isolation from different sources has been widely evaluated, there is a need to better understand the R. equi epidemiology from samples of the nasal cavity of healthy horses. Objectives: To determine the prevalence of R. equi from the nasal cavity of healthy horses, along with its virulence profile, antimicrobial susceptibility and environmental variables associated. Study design: Cross‐sectional study. Methods: Swabs from the nasal cavity of 1010 apparently healthy horses from 341 farms were submitted for bacteriological analyses. The identity and virulence profile of the R. equi isolates were assessed by multiplex PCR; antimicrobial susceptibility was determined by the disk‐diffusion method. The occurrence of R. equi was calculated at the level of both animal and farm. The association of seven specific environmental factors with R. equi isolation was assessed using logistic regression and by a spatial scan statistical method to determine the presence of local clusters. Results: Antimicrobial‐sensitive R. equi was isolated from 10 (1%) of 1010 horses ranging between 3 and 29 years old. Ten farms (3%) had at least one positive horse. Only one R. equi isolate (10%) was classified as virulent. Red‐Yellow Argisol (PVA/PV) soils were significantly associated with R. equi isolation (odds ratio (OR) 8.02; CI95%, 1.98–32.50, P = 0.01), and areas with well‐drained soil were less likely to be test positive (OR 0.85; CI95%, 0.76–0.96, P = 0.03). Main limitations: The use of culture‐based method instead of PCR‐based assay and the lack of soil sampling. Conclusions: Antimicrobial‐sensitive R. equi may be considered a minor part of the normal bacterial flora in the nasal cavity of healthy and immunologically functional horses breeding on pasture. Further studies are warranted to determine if soils rich in iron and well‐drained are, in fact, associated with the occurrence of R. equi. [ABSTRACT FROM AUTHOR]

Contents This study evaluated the reproductive performance of gilts inseminated at three intervals before ovulation (0–12, 13–23, 24–30 h) with sperm doses (SD) stored for 0–48 and 96–120 h. A total of 218 PIC Camborough 22® gilts were inseminated once with SD of 1.5 × 109 sperms. Pregnant gilts (n = 166) were slaughtered 30.8 ± 3.7 days after artificial insemination. The number of corpora lutea (CL) and total embryos (TE) was counted. Pregnancy rates (PR) were analysed by chi-square test. TE and embryonic survival (ES), obtained as the ratio between viable embryos and CL, were analysed by GLM procedure (SAS) and mean values were compared by Tukey's test. Pregnancy rate was similar among artificial insemination–ovulation (AIOV) intervals when semen was stored for 0–48 h. However, the lowest PR was observed in the 24–30 h AIOV interval with storage time (ST) of 96–120 h (p < 0.05). There was a significant effect of the interaction between ST and AIOV (p < 0.05) on TE and ES variables. Total embryos and ES did not differ (p > 0.05) among AIOV intervals in ST of 0–48 h. However, gilts inseminated at 24–30 h AIOV interval with ST of 96–120 h showed a reduction of 6.7 embryos (p < 0.05) compared with gilts in the same interval inseminated with semen stored for 0–48 h. ES for the 24–30 h AIOV interval and ST of 96–120 h was lower than that observed in the other groups (p < 0.05). [ABSTRACT FROM AUTHOR]

Presents a letter to the editor which states that loss of TNF-related apoptosis-inducing ligand receptor does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice.

Based on 51Cr release from an allogeneic human melanoma cell (M I) cell-mediated (CMC) and antibody-dependent cellular cytotoxicity (ADCC) were determined in twenty-eight melanoma patients, thirty-one healthy controls, ten patients with other tumours and eleven chronic lymphocytic leukaemia CLL) patients. The results were related to simultaneously performed microcytotoxicity (MC) tests. HL-A typing, plasma membrane fluorescence and B:T cell ratios in the peripheral blood. Furthermore, lymphocytes from six melanoma patients were tested in CMC and ADCC assays against autologous tumour cells. The following results were obtained. (1) A large number of healthy controls possessed lymphocytes which readily lysed M1 target cells in CMC and MC assays. (2) CMC activity of lymphocytes from melanoma patients was generally lower than that of control lymphocytes and decreased further with progression of the disease. (3) CLL lymphocytes were virtually non-toxic for Ml cells, even at high aggressor:target cell ratios. (4) ADCC assays with a heterologous rabbit-anti-MI serum showed generally higher isotope release than CMC assays; this was particularly pronounced in the melanoma group and in the group of patients with other tumours. (5) No tumour-specific blocking factor could be detected in melanoma sera, as judged by the capacity of the sera to block CMC activity. (6) No obvious correlation was found between the results obtained in short-term CMC and long-term MC assays. (7) T lympho-cyctes, as determined by E-rosette formation, were significantly diminished in melanoma patients. (8) The HL-A type of lymphocytes from normal donors and melanoma patients did not appear to be related to high or low activity in CMC and MC assays. (9) Preliminary results of 51Cr release tests with autologous melanoma cells were encouraging with respect to the correlation of the results to the clinical course of the disease. [ABSTRACT FROM AUTHOR]